<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2772">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03313895</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001135</org_study_id>
    <nct_id>NCT03313895</nct_id>
  </id_info>
  <brief_title>The ACT Trial: Effects of Combined Aerobic Exercise and Cognitive Training in MCI</brief_title>
  <official_title>Efficacy and Mechanisms of Combined Aerobic Exercise and Cognitive Training (ACT) in MCI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of St Thomas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site clinical trial occurs at the University of Minnesota and University of&#xD;
      Rochester. It tests the efficacy and additive/synergistic effects of an ACT intervention on&#xD;
      cognition and relevant mechanisms (aerobic fitness, Alzheimer's disease [AD] signature&#xD;
      cortical thickness, and default mode network [DMN]) in older adults with amnestic MCI (aMCI).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Because almost all drug trials for Alzheimer's disease (AD) have failed, developing&#xD;
      non-pharmacological interventions with strong potential to prevent or delay the onset of AD&#xD;
      in high-risk populations (e.g., those with mild cognitive impairment [MCI]) is critically&#xD;
      important. Aerobic exercise and cognitive training are 2 promising interventions for&#xD;
      preventing AD. Aerobic exercise increases aerobic fitness, which in turn improves brain&#xD;
      structure and function, while cognitive training improves selective neural function&#xD;
      intensively. Hence, combined Aerobic exercise and Cognitive Training (ACT) may very well have&#xD;
      an additive or synergistic effect on cognition by complementary strengthening of different&#xD;
      neural functions. Few studies have tested ACT's effects, and those studies have reported&#xD;
      discrepant findings, largely due to varying ACT programs. The purpose of this single-blinded,&#xD;
      2×2 factorial Phase II randomized controlled trial (RCT) is to test the efficacy and&#xD;
      additive/synergistic effects of a 6-month combined cycling and speed of processing (SOP)&#xD;
      training intervention on cognition and relevant mechanisms (aerobic fitness, AD signature&#xD;
      cortical thickness, and functional connectivity in the default mode network [DMN]) in older&#xD;
      adults with amnestic MCI (aMCI).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cognition</measure>
    <time_frame>Change from baseline to 3, 6, 12, and 18 months</time_frame>
    <description>Change in the composite measures of executive function and episodic memory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AD-signature cortical thickness</measure>
    <time_frame>Change from baseline to 6, 12, and 18 months</time_frame>
    <description>measured by the Magnetic Resonance Imaging (MRI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional connectivity</measure>
    <time_frame>Change from baseline to 6, 12, and 18 months</time_frame>
    <description>measured by functional MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aerobic fitness</measure>
    <time_frame>Change from baseline to 3, 6, 12, and 18 months</time_frame>
    <description>measured by the symptom-limited peak cycle-ergometer test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion to Alzheimer's diseae</measure>
    <time_frame>Change in clinical status from MCI to AD at 6, 12, and 18 months</time_frame>
    <description>Change in memory, global cognition, and instrumental activities of daily living will be assessed to make a clinical decision if a participant has progressed from MCI to AD</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Cycling Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Moderate-intensity cycling, 3 times a week for 6 months, supervised by an exercise specialist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cognitive Training Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Computerized cognitive training, 3 times a week for 6 months, supervised by a specialist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moderate-intensity cycling followed by computerized cognitive training, 3 times a week for 6 months, supervised by a specialist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching and Mental Stimulation Activities</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stretching and mental stimulation activities, 3 times a week for 6 months, supervised by a specialist</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ACT</intervention_name>
    <description>ACT stands for combined aerobic exercise and cognitive training.</description>
    <arm_group_label>ACT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cycling Only</intervention_name>
    <description>Cycling on a recumbent stationary cycle</description>
    <arm_group_label>Cycling Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Training Only</intervention_name>
    <description>Engage in cognitive training on a computer</description>
    <arm_group_label>Cognitive Training Only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stretching and Mental Stimulating Activities</intervention_name>
    <description>Stretching exercises and mental stimulating activities on a computer</description>
    <arm_group_label>Stretching and Mental Stimulation Activities</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A clinical diagnosis of MCI, Community-dwelling, Age 65 years and older,&#xD;
             English-speaking, Adequate visual acuity, Verified exercise safety by medical&#xD;
             provider, Stable on drugs affecting cognitive and psychological status, Verified MRI&#xD;
             safety, and Capacity to consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Geriatric Depression Scale &lt; 5, Resting heart rate (HR) ≤50 due to arrhythmia or ≥100&#xD;
             beats/min, Neurological (e.g., dementia, head trauma), psychiatric (e.g., bipolar,&#xD;
             schizophrenia, or depression), or substance dependency (alcohol or chemical&#xD;
             dependency) in the past 5 years that are the main contributor to MCI,&#xD;
             Contraindications to exercise, e.g. unstable angina, recent surgery, New symptoms or&#xD;
             diseases that have not been evaluated by a health care provider, Current enrollment in&#xD;
             another intervention study related to cognitive improvement (reduce confounding&#xD;
             effects on outcomes), and Abnormal MRI findings.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fang Yu, PhD</last_name>
    <phone>602-496-0969</phone>
    <email>Fang.Yu.2@asu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hector Cervanes, MS</last_name>
    <phone>602-496-2292</phone>
    <email>hcervant@asu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hector Cervanes, MS</last_name>
      <phone>602-496-2292</phone>
      <email>hcervant@asu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ferdinand Delgado, MS</last_name>
      <email>fdelgad5@asu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Fang Yu, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Russell Spafford, MS</last_name>
      <phone>612-625-3548</phone>
      <email>spaff010@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dereck Salisbury, PhD</last_name>
      <phone>612-625-9939</phone>
      <email>salis048@umn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dereck Salisbury, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Verhoef, MS</last_name>
      <phone>585-276-6834</phone>
      <email>Nicholas_verhoef@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Kathi Heffner, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 6, 2017</study_first_submitted>
  <study_first_submitted_qc>October 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2017</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

